刘伟丽, 卞士中, 顾振纶, 等. 氯胺酮成瘾机制的研究进展[J]. 法医学杂志, 2009, 25(3): 200-207.Liu Weili, Bian Shizhong, Gu Zhenlun, et al. Advances in Research of Ketamine Addiction Mechanism[J]. Journal of Forensic Medicine, 2009, 25(3): 200-207(in Chinese).
[2]
Jia SW, Wang W, Liu Y, et al. Neuroimaging studies of brain corpus striatum changes among heroin-dependent patients treated with herbal medicine, U'finer capsule[J]. Addict Biol, 2005, 10(3): 293-297.
[3]
贾少微, 吴子明, 罗惠恩, 等. 99Tcm-TRODAT-1显像在君复康胶囊防治毒品复吸中的应用[J]. 中华核医学杂志, 2004, 24(3): 155-157.Jia Shaowei, Wu Ziming, Luo Huien, at a1. The value of dopamine transporter99Tcm-TRODAT-1 imaging for evaluating the therapeutic effects of Junfukang capsule on prevention and cure of drug addiction recurrence[J]. Chinese Journal of Nuclear Medicine, 2004, 24(3): 155-157(in Chinese)..
[4]
吴子明, 贾少微, 罗惠恩, 等. 君复康胶囊用于控制稽延性戒断症状的临床评价[J]. 中国药物依赖性杂志, 2004, 13(1): 50-54.Wu Ziming, Jia Shaowei, Luo Huien, et a1. Clinical Observation on U'finertm Capsules for the Control of Heroin Induced Prolonged Withdrawal Symptoms[J]. Chinese Journal of Drug Dependence, 2004, 13(1): 50-54(in Chinese)..
[5]
贾少微, 时杰, 高宙, 等. 脑多巴胺转运蛋白99Tcm-TRADOT-1显像研究[J]. 中华核医学杂志, 2003, 23(增刊): 40-43.Jia Shaowei, Shi Jie, Gao Zhou, at a1. Imaging study of brain dopamine transporter imaging adent99Tcm-TRADOT-1[J]. Chinese Journal of Nuclear Medicine, 2003, 23(zl): 40-43(in Chinese)..
[6]
Chou YH, Huang WS, Su TP, et al. Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study[J]. Eur Neuropsycho pharmacol, 2007, 17(1): 46-52.
[7]
〖LL〗Trujillo KA, Zamora JJ, Warmoth KP. Increased response to ketamine following treatment at long intervals: implications for intermittent use[J]. Biol Psychiatry, 2008, 63(2): 178-183.
[8]
Rofael HZ, Abdel-Rahman MS. The role of ketamine on plasma cocaine pharmacokinetics in rat[J]. Toxicol Lett, 2002, 129(1-2): 167-176.
[9]
杨菊, 卞士中. 氯胺酮滥用的研究进展[J]. 法医学杂志, 2007, 23(4): 312-315.Yang Ju, Bian Shizhong. A Reviewing for Abusing of Ketamine[J]. Journal of Forensic Medicine, 2007, 23(4): 312-315(in Chinese)..
[10]
Vollenweider FX, Vontobel P, Oye I, et al. Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans[J]. J Psychiatr Res, 2000, 34(1): 35-43.
[11]
Aalto S, Ihalainen J, Hirvonen J, et al. Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man[J]. Psychopharmacology (Berl), 2005, 182(3): 375-383.
[12]
Narendran R, Frankle WG, Keefe R, et al.Altered prefrontal dopaminergic function in chronic recreational ketamine users[J]. Am J Psychiatry, 2005, 162(12): 2352-2359.
[13]
Tsukada H, Nishiyama S, Kakiuchi T, et al. Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain[J]. Synapse, 2001, 42(4): 273-280.
[14]
孙涛涛, 胡疏, 贾少微, 等. 复方磷酸可待因口服液依赖者多巴胺转运蛋白SPECT显像[J]. 中华核医学杂志, 2010, 30(6): 379-382.Sun Taotao, Hu Shu, Jia Shaowei, et al. Dopamine transporter SPECT imaging of the peroral adductors of compound codeine phosphate solution[J]. Chinese Journal of Nuclear Medicine, 2010, 30(6): 379-382(in Chinese)..
[15]
贾少微, 时杰, 欧阳钢, 等. 应用单光子发射计算机体层摄影术研究药物滥用对人脑纹状体多巴胺转运体的损害[J]. 中华精神科杂志, 2005, 38(2): 69-72.Jia Shaowei, Shi Jie, Ouyang Gang, et al. Drug abuse on corpus striatum dopamine transporter: a single photon emission computed tomography imaging study[J]. Chinese Journal of Psychiatry, 2005, 38(2): 69-72(in Chinese)..
